Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
Shilling H, Garland SM, Atchison S, Cornall AM, Brotherton JML, Bateson D, McNamee K, Kaldor JM, Hocking JS, Chen MY, Fairley CK, McNulty A, Bell C, Marshall L, Ooi C, Skinner SR, Murray G, Molano M, Tabrizi S, Machalek DA.
Shilling H, et al. Among authors: bell c.
Vaccine. 2021 Aug 9;39(34):4856-4863. doi: 10.1016/j.vaccine.2021.07.005. Epub 2021 Jul 17.
Vaccine. 2021.
PMID: 34281743